Altogether, our results suggest that CD38+ macrophages are associated with an M1 phenotype that is characterized by higher CD80 expression and a pro-inflammatory cytokine profile, all of which contribute to the anti-tumor immune response. This evidence concerns the gene CD80 and neoplasm.